Similar conclusions were also presented by Xu et al. [96], who showed that serum POSTN concentrations in patients with NSCLC (tested via ELISAs) were significantly elevated compared to those in patients with a mild lung disease and healthy controls. The gene discussed is POSTN; the disease is non-small cell lung carcinoma.